Pricing Log in Create free account

MannKind Corporation (MNKD) vs Vor Biopharma Inc. (VOR)

MannKind Corporation and Vor Biopharma Inc. are both Biotechnology companies. MannKind Corporation and Vor Biopharma Inc. are of similar size ($1.2B and $1.2B). Vor Biopharma Inc. has the higher net margin (0.00% vs −18.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Vor Biopharma Inc. leads on 6 and MannKind Corporation on 5.

Valuation

Metric MNKD VOR Biotechnology median
P/E n/m n/m 10.60
P/S 3.04 n/m 9.40
P/B n/m 0.38 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 50.23 0.50 0.66
EV/Sales 3.82 n/m 9.02
Earnings yield (5.87%) (1,910.79%) (32.88%)
Free cash flow yield (6.25%) (141.07%) (23.13%)

Profitability

Metric MNKD VOR Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin (2.88%) — 0.00%
Net margin (18.10%) 0.00% 0.00%
Free cash flow margin (18.97%) 0.00% 0.00%
Return on equity 182.90% (69.27%) (51.96%)
Return on assets (12.29%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MNKD VOR Biotechnology median
Revenue growth (TTM) 31.74% — 6.76%
EPS growth (last fiscal year) (80.00%) (107.35%) 29.88%
Revenue growth, 5-year CAGR 39.89% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNKD VOR Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 2.22 10.69 4.97
Net debt to EBITDA 5.32 2.27 1.01

Dividend

Metric MNKD VOR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MNKD VOR Biotechnology median
Market cap 1.21b 1.15b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack